Sanofi acquires Kymab with a focus on immune and inflammatory diseases

Sanofi acquires immune and inflammatory disease specialist Kymab

Sanofi has acquired Kymab, a clinical-stage biopharmaceutical company based in Cambridge, developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology...
Merger Agreement for Astellas Pharma Inc and iota biosciences

Merger Agreement for Astellas Pharma Inc and iota Biosciences

Astellas Pharma Inc. and iota Biosciences, Inc. have announced that Astellas, through a U.S. subsidiary, and iota have entered into a Merger Agreement, with...
RBW Consulting and Thorp Associates announces merger, with new Chief Growth Officer

Merger announced between RBW Consulting and Thorp Associates, with new Chief Growth Officer

A merger has been announced between RBW Consulting, specialist life science and technology search consultancy, and Thorp Associates, executive search and selection company. Emma Thorp,...

AbbVie to acquire Allergan in “transformative move”

Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...

Novartis acquires IFM Tre

Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...

GHO Capital acquires Sterling Pharma Solutions

European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...

Healthtech M&A and IPO Activity

The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...

DoseCare acquires Biodose

DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...

UK pharma pressing ahead with M&As in 2019

The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...

Sanofi and Denali join forces on inflammatory disease drugs

Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...

Latest articles

NICE recommendation for UCB’s bimekizumab for the treatment of severe plaque psoriasis

NICE recommendation for UCB’s bimekizumab as treatment for severe plaque psoriasis

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination, recommending UCB’s bimekizumab as an option for the treatment...
Amanda Pritchard appointed new Chief Executive Officer of NHS England

Amanda Pritchard appointed new Chief Executive Officer of NHS England

The first woman to lead NHS England, Amanda Pritchard, has been appointed and will take up her post on Sunday August 1. She takes...
Study shows AZ’s COVID-19 vaccine did not increase the rate of rare blood clots after second dose

Study shows AZ’s COVID-19 vaccine did not increase rate of rare blood clots after...

Data published in The Lancet has demonstrated that AstraZeneca’s COVID-19 jab Vaxzevria (formerly AZD1222) does not increase the rate of rare blood clots after...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NICE recommendation for UCB’s bimekizumab for the treatment of severe plaque psoriasis

NICE recommendation for UCB’s bimekizumab as treatment for severe plaque psoriasis

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination, recommending UCB’s bimekizumab as an option for the treatment...
ABPI Code & digital content myth-busting

ABPI Code & digital content myth-busting

Dr Rina Newton busts some myths to demonstrate the commercial wins when ABPI code compliance is not considered digital content’s arch nemesis. Top ten takeaways 1....
Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace

Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace

As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these reforms that...
Nasal spray to protect against COVID-19 is ready for use in humans

Nasal spray to protect against COVID-19 is ready for use in humans

A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription